WestPark Capital, a full-service investment bank and broker-dealer, announced today that Ed Arce has joined the firm as a Managing Director and Senior Research Analyst covering emerging and small-to-midcap (SMID) biotechnology companies. Ed is highly regarded in the industry with deep knowledge across a number of therapeutic areas, bringing nearly 20 years of research experience. Prior to joining WestPark, Ed worked as a healthcare analyst at H.C. Wainwright, Roth Capital Partners, MLV & Co., Wedbush Securities and UBS Securities.

Said Jason Stern, COO of WestPark: “We are thrilled to have Ed bring his expertise to our growing team and help us continue to grow our footprint in key growth sectors such as healthcare.”

About WestPark Capital, Inc.

WestPark Capital is a full-service investment bank focused on emerging growth sectors such as healthcare, software, technology, biotechnology, financial services, manufacturing, consumer products, media and telecom industries, among other categories. WestPark Capital provides a comprehensive range of corporate finance services, including initial public offerings, follow-on offerings, private placements, CMPOs, RDs, ATM, SIPOs and corporate finance advisory services. Additional information about WestPark Capital is available at www.wpcapital.com or at info@wpcapital.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250806768169/en/